Location History:
- Elizabeth, NJ (US) (2011 - 2016)
- Bexley, OH (US) (2016)
Company Filing History:
5 out of 272 
4 out of 1,458 
Years Active: 2011-2016
Title: **Noah Weisleder: Innovator in Biomedical Research**
Introduction
Noah Weisleder, based in Elizabeth, NJ, has made significant contributions to the field of biomedical research, holding a total of nine patents. His work primarily focuses on the development of novel therapeutic and diagnostic approaches for various diseases, particularly those related to tissue injury and proliferative disorders.
Latest Patents
Weisleder's recent patents include innovative advancements such as "ATAP peptides, nucleic acids encoding the same and associated methods of use." This invention discloses nucleic acid sequences that encode pro-apoptotic polypeptides, as well as the polypeptides themselves, antibodies that specifically bind to these polypeptides, and their derivatives. The applications of this invention extend to therapeutic, diagnostic, and research methods aimed at the diagnosis, treatment, and prevention of proliferative disorders and bacterial infections.
Another noteworthy patent is "Serum MG53 as a diagnostic marker for tissue injury." This patent outlines compositions and methods for measuring the level of MG53 in biological fluids as a biomarker for conditions such as tissue damage and muscle-related disorders. Furthermore, the invention proposes targeting native MG53 found in blood for therapeutic interventions.
Career Highlights
Throughout his career, Noah Weisleder has collaborated with esteemed institutions such as the University of Medicine and Dentistry of New Jersey and Rutgers, the State University of New Jersey. His contributions to these organizations have cemented his position as a notable inventor in the biomedical field.
Collaborations
Weisleder has worked alongside talented individuals including Jianjie Ma and Chuanxi Cai, enhancing the collaborative spirit of innovation in his projects. Their combined efforts have led to significant advancements in research methodologies and therapeutic strategies.
Conclusion
Noah Weisleder exemplifies the innovative spirit within the realm of biomedical research. His nine patents illustrate a commitment to developing solutions for complex medical challenges, making him a prominent figure in the scientific community. As he continues to explore new avenues of research, his contributions are sure to have a lasting impact on the field and beyond.